Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

Although the efficacy of lopinavir/ritonavir has not been proven, it has been proposed as an off-label treatment for COVID-19. Previously, it has been reported that the plasma concentrations of lopinavir significantly increase in inflammatory settings. As COVID-19 may be associated with major inflam...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Drug Monit
Main Authors: Chouchana, Laurent, Boujaafar, Sana, Gana, Ines, Preta, Laure-Hélène, Regard, Lucile, Legendre, Paul, Azoulay, Celia, Canouï, Etienne, Zerbit, Jeremie, Carlier, Nicolas, Terrier, Benjamin, Kernéis, Solen, Batista, Rui, Treluyer, Jean-Marc, Zheng, Yi, Benaboud, Sihem
Formato: Artigo
Idioma:Inglês
Publicado em: Therapeutic Drug Monitoring 2021
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7808275/
https://ncbi.nlm.nih.gov/pubmed/33230045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000838
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados